Date published: 2025-12-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

TFPI-2 Inhibitors

TFPI-2 inhibitors are a class of chemical compounds that specifically target tissue factor pathway inhibitor-2 (TFPI-2), a protein involved in regulating extracellular proteolysis and maintaining extracellular matrix integrity. TFPI-2 is a member of the Kunitz-type serine protease inhibitor family, and it functions primarily by inhibiting a variety of proteases, including plasmin, trypsin, and matrix metalloproteinases (MMPs). By inhibiting these proteases, TFPI-2 plays a crucial role in controlling processes such as tissue remodeling, cell migration, and the degradation of the extracellular matrix. Inhibitors of TFPI-2 disrupt its normal regulatory function by preventing it from interacting with and inhibiting its target proteases, leading to an increase in proteolytic activity in the extracellular environment. This can result in significant changes in the behavior of cells and the surrounding tissue architecture due to the altered balance of protease activity.

The development of TFPI-2 inhibitors typically involves identifying molecules that can selectively bind to TFPI-2 and interfere with its inhibitory action on proteases. These inhibitors may function by binding to the Kunitz domains of TFPI-2, which are critical for its interaction with proteases, or by disrupting its overall conformation, thus hindering its ability to regulate proteolytic enzymes effectively. Structural studies of TFPI-2 have provided valuable insights into its functional domains, enabling the design of inhibitors that specifically target these regions without affecting other protease inhibitors. TFPI-2 inhibitors are important tools for studying the role of protease regulation in tissue dynamics and provide a means to explore the biochemical mechanisms underlying extracellular matrix maintenance and protease-mediated processes. These inhibitors offer insights into how TFPI-2 modulates extracellular proteolysis, contributing to a deeper understanding of its role in various biological processes involving cell migration, invasion, and tissue remodeling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$110.00
$400.00
$1615.00
51
(2)

Serine protease inhibitor that can inhibit plasmin, potentially affecting the function of TFPI-2.

Tranexamic acid

1197-18-8sc-204921
sc-204921A
5 g
10 g
$28.00
$49.00
10
(1)

Inhibits plasminogen activation, potentially influencing the function of TFPI-2.

Argatroban

74863-84-6sc-201310
sc-201310A
10 mg
50 mg
$115.00
$460.00
13
(1)

Direct thrombin inhibitor, could potentially affect TFPI-2 function.

Dabigatran

211914-51-1sc-481166
5 mg
$205.00
1
(0)

Another direct thrombin inhibitor, could potentially affect TFPI-2 function.

Warfarin

81-81-2sc-205888
sc-205888A
1 g
10 g
$72.00
$162.00
7
(1)

Anticoagulant that inhibits vitamin K reductase, potentially affecting coagulation and TFPI-2 function.

Heparin

9005-49-6sc-507344
25 mg
$117.00
1
(0)

Anticoagulant that enhances antithrombin III, potentially influencing the function of TFPI-2.

Fondaparinux

104993-28-4sc-507424
10 mg
$297.00
(0)

Factor Xa inhibitor, could potentially affect TFPI-2 function.

Rivaroxaban

366789-02-8sc-208311
2 mg
$155.00
18
(1)

Another factor Xa inhibitor, could potentially affect TFPI-2 function.